Financials
- Market Capitalization 218.92 M
- Employee 228
- Founded 2008
- CEO N/A
- Website www.karyopharm.com
- Headquarter Delaware, United States
- FIGI BBG001J272L7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3566 | CGEN Compugen Ltd. - Ordinary Shares | 2.35 USD | +2.17% | 0.00% | +16.34% | +52.60% | 222.20 M USD | ||
| 3567 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.70 USD | +0.27% | -4.88% | -7.50% | +25.85% | 221.56 M USD | ||
| 3589 | NBP NovaBridge Biosciences - American Depositary Shares | 1.83 USD | +1.67% | -3.17% | +13.66% | -59.42% | 211.15 M USD | ||
| 3596 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.19 USD | -0.48% | +0.24% | +0.96% | -45.73% | 211.06 M USD |
Frequently asked questions about Karyopharm Therapeutics Inc. - Common Stock
What is the Karyopharm Therapeutics Inc. - Common Stock stock price today?
The current price of Karyopharm Therapeutics Inc. - Common Stock (KPTI) is 9.66. Over the past 24 hours, the stock has changed by -3.50%. Follow the KPTI chart for real-time price dynamics.
What is the stock ticker of Karyopharm Therapeutics Inc. - Common Stock?
Karyopharm Therapeutics Inc. - Common Stock trades under the ticker KPTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Karyopharm Therapeutics Inc. - Common Stock stock going up?
KPTI has changed by -7.56% over the last week, +0.21% over the last month, and +0.21% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Karyopharm Therapeutics Inc. - Common Stock net income for the last quarter?
Karyopharm Therapeutics Inc. - Common Stock reported net income of -22.39 M for the last quarter. The previous quarter showed -102.2 M, which means net income changed by +78.09%.
How many employees does Karyopharm Therapeutics Inc. - Common Stock have?
As of the latest available data, Karyopharm Therapeutics Inc. - Common Stock has 228 employees. Workforce size can provide additional context about the company's scale and operations.
What is Karyopharm Therapeutics Inc. - Common Stock EBITDA?
Karyopharm Therapeutics Inc. - Common Stock EBITDA is -31.3 M, and its EBITDA margin is -111.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Karyopharm Therapeutics Inc. - Common Stock stock?
You can buy Karyopharm Therapeutics Inc. - Common Stock (KPTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Karyopharm Therapeutics Inc. - Common Stock stock?
Investing in Karyopharm Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KPTI chart and related analysis on metatrader.com as part of your research.